Skip to content

News Archives

 

BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion

BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion
PEI's BioVectra Inc. announced today a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to manufacture Ferric Citrate, the active pharmaceutical ingredient (API) in Auryxia® tablets - a medicine approved for the treatment of two common complications of chronic kidney disease.
Scroll To Top